Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.47 HKD | +7.83% | +8.92% | -3.14% |
04-15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
04-15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
Sales 2023 | 246M 34M 266M 2.72B | Sales 2024 * | 444M 61.22M 479M 4.9B | Capitalization | 4.15B 573M 4.49B 45.91B |
---|---|---|---|---|---|
Net income 2023 | -380M -52.44M -411M -4.2B | Net income 2024 * | -251M -34.64M -271M -2.77B | EV / Sales 2023 | 17 x |
Net cash position 2023 * | 962M 133M 1.04B 10.63B | Net cash position 2024 * | 937M 129M 1.01B 10.36B | EV / Sales 2024 * | 7.25 x |
P/E ratio 2023 |
-10.3
x | P/E ratio 2024 * |
-16.6
x | Employees | 444 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 47.57% |
1 day | +7.83% | ||
1 week | +8.92% | ||
Current month | +11.94% | ||
1 month | +12.91% | ||
3 months | +24.42% | ||
6 months | -11.00% | ||
Current year | -3.14% |
Managers | Title | Age | Since |
---|---|---|---|
Ye Liu
CEO | Chief Executive Officer | 53 | 31/07/18 |
Tim Ruan
DFI | Director of Finance/CFO | 38 | 11/01/23 |
Dong Hong Chen
CTO | Chief Tech/Sci/R&D Officer | 53 | 27/10/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Li
BRD | Director/Board Member | 52 | 31/03/18 |
Yan Ling Cao
BRD | Director/Board Member | 39 | 17/06/19 |
Ting Yuk Wu
BRD | Director/Board Member | 69 | 22/06/20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.59% | 4 M€ | -27.92% | ||
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 6.47 | +7.83% | 1,504,500 |
25/04/24 | 6 | -0.50% | 1,037,500 |
24/04/24 | 6.03 | +1.17% | 976,000 |
23/04/24 | 5.96 | +2.05% | 232,000 |
22/04/24 | 5.84 | -1.68% | 534,000 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 09:08 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.14% | 573M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 1477 Stock